Clinical trial
A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa (LOTUS)
NCT06603077 is registered in ClinicalTrials.gov with Avalo Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa (LOTUS)
- Lead sponsor
- Avalo Therapeutics, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 16, 2024
- Completion date
- March 17, 2026
- Enrollment
- 253 (actual)
- Sites
- 89
Conditions
As the registry lists them; a condition with its own page is linked.